🔴 Oncolytics Biotech is trading 5% down

Oncolytics Biotech is trading 5.28% down now at $0.44, with no verified October 28 company-specific announcement directly explaining the drop.

• Shares closed at $0.47 on October 26 and $0.46 on October 27, followed by a further decline.
• The company reported positive GOBLET anal-cancer data on October 27, but that prior-day update does not establish a reason for the current decline.
• Biotech stocks were reported up 2.18%, so sector strength does not explain the move.